Google Übersetzer
Lisata Therapeutics, Inc.
About
Lisata Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 6 2026
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Jan 27 2026
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
Jan 21 2026
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Dec 4 2025
LSTA Releases Valuations Report on Level 3 Loans
Nov 6 2025
Lisata Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Recent Videos
LISATA THERAPEUTICS, INC. (0000320017) (Filer) #Shorts
Apr 17, 2026
My Take: Lisata Therapeutics Deal in Doubt After 8-K Filing
Apr 17, 2026
LSTA STOCK : FRESH BREAKOUT | LISATA THERAPEUTICS STOCK
Apr 12, 2026
LSTA STOCK : FRESH MOMENTUM | LISATA THERAPEUTICS STOCK
Feb 21, 2026